FDA intensifies US safety analysis probing into AstraZeneca coronavirus vaccine
US Regulators had ceased Phase 3 clinical trials of AstraZeneca coronavirus vaccine from September 6. The in-depth analysis of FDA ...
Tag: Covid vaccine
Can the government afford COVID-19 vaccines worth Rs 80,000 crore?
THD NewsDesk, Pune: In a tweet, Adar Poonawalla, CEO of Serum Institute, has raised a question that reasonably resides in ...
COVID-19 drug formulations undertaking clinical trials at IIM Jammu, says institute Director
THD NewsDesk, Jammu: The Indian Institute of Integrative Medicine of Jammu (IIIM) is currently conducting trials of 3-4 formulations of ...
COVID-19 Vaccine Will Cost Less Than the Price of a Water Bottle
THD NewsDesk, Hyderabad: A conference conducted at the Genome Valley, Hyderabad, facilitated a discussion on the theme, “COVID-19 vaccine and science” ...
Pfizer Inc, BioNTech advice to increase the number of COVID-19 vaccine trial volunteers
THD NewsDesk, New Delhi: Pfizer Inc and BioNTech SE on Saturday suggested to the U.S. Food and Drug Administration (FDA) ...
Is the Oxford COVID-19 vaccine candidate safe?
THD NewsDesk, London: AstraZeneca, a pharmaceutical company said it had "voluntarily paused" a random clinical examination on Tuesday, 8th of ...
Serum Institute of India initiates the production of Codagenix’s nasal COVID-19 vaccine
THDNewsDesk, Pune: Recently, The Serum Institute of India has commenced the production of the COVID-19 vaccine candidate. Codagenix Inc, the US ...
AstraZeneca intends for ‘Covishield’ vaccine to hit the market before year-end: CEO
THDNewsDesk, New Delhi: Pharma Gaints AstraZeneca recently said that their Covid-19 vaccine development with Oxford University could be ready shortly. ...
China sends out indigenous COVID-19 vaccines for human trials
THD NewsDesk: As reported earlier this week, China has initiated to showcase its homegrown vaccines for the first time. The ...
Coronavirus Mutation raises Concerns Amidst Vaccine Distribution Plans
THD NewsDesk, LONDON: As Russia sets to start its COVID-19 vaccine trials on 40,000 people after 23rd August 2020, concerns ...
